Price Chart

Profile

Pharvaris NV is a clinical-stage company. It is focused on the discovery and development and commercialization of therapies for rare diseases with significant unmet need, initially focused on angioedema and other bradykinin-mediated diseases. The company's activities are considered to be one segment which comprises the discovery, development and commercialization of oral bradykinin-B2-receptor antagonists .
URL https://www.pharvaris.com
Investor Relations URL N/A
HQ State/Province N/A
Sector Health Care
Industry Pharmaceuticals
Equity Style Small Cap/Growth
Next Earnings Release Apr. 10, 2025 (est.)
Last Earnings Release Nov. 13, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Pharvaris NV is a clinical-stage company. It is focused on the discovery and development and commercialization of therapies for rare diseases with significant unmet need, initially focused on angioedema and other bradykinin-mediated diseases. The company's activities are considered to be one segment which comprises the discovery, development and commercialization of oral bradykinin-B2-receptor antagonists .
URL https://www.pharvaris.com
Investor Relations URL N/A
HQ State/Province N/A
Sector Health Care
Industry Pharmaceuticals
Equity Style Small Cap/Growth
Next Earnings Release Apr. 10, 2025 (est.)
Last Earnings Release Nov. 13, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A